Found: 79
Select item for more details and to access through your institution.
Schedule-dependent Efficacy of Camptothecins in Models of Human Cancer<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 188, doi. 10.1111/j.1749-6632.1996.tb26388.x
- By:
- Publication type:
- Article
Development and Validation of a Sensitive and Specific LC-MS/MS Method for IWR-1-Endo, a Wnt Signaling Inhibitor: Application to a Cerebral Microdialysis Study.
- Published in:
- Molecules, 2022, v. 27, n. 17, p. 5448, doi. 10.3390/molecules27175448
- By:
- Publication type:
- Article
Entinostat as a combinatorial therapeutic for rhabdomyosarcoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-66545-5
- By:
- Publication type:
- Article
Using the LeiCNS-PK3.0 Physiologically-Based Pharmacokinetic Model to Predict Brain Extracellular Fluid Pharmacokinetics in Mice.
- Published in:
- Pharmaceutical Research, 2023, v. 40, n. 11, p. 2555, doi. 10.1007/s11095-023-03554-5
- By:
- Publication type:
- Article
Relation of systemic exposure to unbound etoposide and hematologic toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 50, n. 4, p. 385, doi. 10.1038/clpt.1991.155
- By:
- Publication type:
- Article
Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 4, p. 540, doi. 10.1038/clpt.1990.69
- By:
- Publication type:
- Article
Altered protein binding of etoposide in patients with cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 45, n. 1, p. 49, doi. 10.1038/clpt.1989.8
- By:
- Publication type:
- Article
Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion.
- Published in:
- Clinical Pharmacology & Therapeutics, 1983, v. 33, n. 3, p. 301, doi. 10.1038/clpt.1983.37
- By:
- Publication type:
- Article
Corrigendum: Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
- Published in:
- Nature Genetics, 2015, v. 47, n. 4, p. 423, doi. 10.1038/ng0415-423
- By:
- Publication type:
- Article
Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss.
- Published in:
- Nature Genetics, 2015, v. 47, n. 3, p. 263, doi. 10.1038/ng.3217
- By:
- Publication type:
- Article
CNS Penetration of Cyclophosphamide and Metabolites in Mice Bearing Group 3 Medulloblastoma and Non-Tumor Bearing Mice.
- Published in:
- Journal of Pharmacy & Pharmaceutical Sciences, 2019, v. 22, p. 612
- By:
- Publication type:
- Article
Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 3, p. 253
- By:
- Publication type:
- Article
Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumors.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy.
- Published in:
- Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 6, p. 541, doi. 10.5863/1551-6776-26.6.541
- By:
- Publication type:
- Article
69. Selection of Hematopoietic Progenitor and Stem Cells in Transplanted Rhesus Macaques Using MGMT and HOXB4 Lentiviral Vectors.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S29, doi. 10.1016/j.ymthe.2006.08.085
- By:
- Publication type:
- Article
Phase II evaluation of sunitinib in the treatment of recurrent or refractory high-grade glioma or ependymoma in children: a children's Oncology Group Study ACNS1021.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 7, p. 1416, doi. 10.1002/cam4.713
- By:
- Publication type:
- Article
Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts.
- Published in:
- PLoS ONE, 2012, v. 7, n. 3, p. 1, doi. 10.1371/journal.pone.0033894
- By:
- Publication type:
- Article
A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Topotecan clearance based on a single sample and a population pharmacokinetic model: Application to a pediatric high‐risk neuroblastoma clinical trial.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30658
- By:
- Publication type:
- Article
A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC‐042).
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 4, p. 1, doi. 10.1002/pbc.28879
- By:
- Publication type:
- Article
Determining success rates of the current pharmacokinetically guided dosing approach of topotecan in pediatric oncology patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 58, n. 3, p. 372, doi. 10.1002/pbc.23075
- By:
- Publication type:
- Article
An LC/ESI–MS/MS method to quantify the PI3K inhibitor GDC‐0084 in human plasma and cerebrospinal fluid: Validation and clinical application.
- Published in:
- Biomedical Chromatography, 2020, v. 34, n. 1, p. N.PAG, doi. 10.1002/bmc.4697
- By:
- Publication type:
- Article
Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection.
- Published in:
- Biomedical Chromatography, 2010, v. 24, n. 6, p. 626, doi. 10.1002/bmc.1338
- By:
- Publication type:
- Article
Application of a highly specific and sensitive fluorescent HPLC method for topotecan lactone in whole blood.
- Published in:
- Biomedical Chromatography, 2009, v. 23, n. 7, p. 707, doi. 10.1002/bmc.1173
- By:
- Publication type:
- Article
Effect of Obesity on the Pharmacokinetics and Pharmacodynamics of Anticancer Agents.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, p. S85, doi. 10.1002/jcph.2326
- By:
- Publication type:
- Article
Bridging Adult Experience to Pediatrics in Oncology Drug Development.
- Published in:
- Journal of Clinical Pharmacology, 2017, v. 57, p. S129, doi. 10.1002/jcph.910
- By:
- Publication type:
- Article
Palmar-plantar erythrodysesthesia syndrome following treatment with high-dose methotrexate or high-dose cytarabine.
- Published in:
- Cancer (0008543X), 2017, v. 123, n. 18, p. 3602, doi. 10.1002/cncr.30762
- By:
- Publication type:
- Article
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 22, p. 5663, doi. 10.1002/cncr.27563
- By:
- Publication type:
- Article
Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 17, p. 4321, doi. 10.1002/cncr.27378
- By:
- Publication type:
- Article
Combination of Cladribine Plus Topotecan for Recurrent or Refractory Pediatric Acute Myeloid Leukemia.
- Published in:
- Cancer (0008543X), 2010, v. 116, n. 1, p. 98, doi. 10.1002/cncr.24712
- By:
- Publication type:
- Article
Phase 1 Study of Oxaliplatin and Irinotecan in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 8, p. 1765, doi. 10.1002/cncr.24175
- By:
- Publication type:
- Article
Phase 1 Study of an Oxaliplatin and Etoposide Regimen in Pediatric Patients With Recurrent Solid Tumors.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 3, p. 655, doi. 10.1002/cncr.24054
- By:
- Publication type:
- Article
Phase II Study of Topotecan in Combination With Dexamethasone, Asparaginase, and Vincristine in Pediatric Patients With Acute Lymphoblastic Leukemia in First Relapse.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 9, p. 1983, doi. 10.1002/cncr.23395
- By:
- Publication type:
- Article
Treating children with acute lymphoblastic leukemia and Down syndrome: Pharmacokinetics provides insight into vincristine therapy.
- Published in:
- Pediatric Blood & Cancer, 2009, v. 52, n. 1, p. 1, doi. 10.1002/pbc.21743
- By:
- Publication type:
- Article
Reducing irinotecan-associated diarrhea in children.
- Published in:
- Pediatric Blood & Cancer, 2008, v. 50, n. 2, p. 201, doi. 10.1002/pbc.21280
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancer.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 47, n. 5, p. 572, doi. 10.1002/pbc.20685
- By:
- Publication type:
- Article
Cyclophosphamide disposition in an anephric child.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 46, n. 1, p. 99, doi. 10.1002/pbc.20558
- By:
- Publication type:
- Article
Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Pharmacokinetic basis for dosing high‐dose methotrexate in infants and young children with malignant brain tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 2, p. 362, doi. 10.1111/bcp.14160
- By:
- Publication type:
- Article
Using plasma topotecan pharmacokinetics to estimate topotecan exposure in cerebrospinal fluid of children with medulloblastoma.
- Published in:
- Neuro-Oncology, 2006, v. 8, n. 2, p. 89, doi. 10.1215/15228517-2005-004
- By:
- Publication type:
- Article
Review of microdialysis in brain tumors, from concept to application: First Annual Carolyn Frye-Halloran Symposium.
- Published in:
- Neuro-Oncology, 2004, v. 6, n. 1, p. 65, doi. 10.1215/S1152851703000103
- By:
- Publication type:
- Article
Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 3, p. 283, doi. 10.1007/s40262-020-00967-y
- By:
- Publication type:
- Article
Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacokinetic Considerations in the Treatment of CNS Tumours.
- Published in:
- Clinical Pharmacokinetics, 2006, v. 45, n. 9, p. 871, doi. 10.2165/00003088-200645090-00002
- By:
- Publication type:
- Article
Developing Therapy for Every Kid With Cancer – Summary of a Scientific Session at the 2023 ASCPT Meeting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 2, p. 185, doi. 10.1002/cpt.3101
- By:
- Publication type:
- Article
The RACE to Develop New Targeted Therapies for Children With CNS Tumors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 434, doi. 10.1002/cpt.1937
- By:
- Publication type:
- Article